Scientific evolution of indications for liver transplantation in hepatocellular carcinoma
10.12464/j.issn.1674-7445.2025064
- VernacularTitle:肝癌肝移植适应证的科学演进
- Author:
Wei SHEN
1
;
Di LU
2
;
Xiao XU
2
Author Information
1. School of Medicine, Zhejiang University, Hangzhou 310012, China.
2. .
- Publication Type:Editorial
- Keywords:
Hepatocellular carcinoma;
Liver transplantation;
Indication;
Alpha-fetoprotein;
Protein induced by vitamin K absence or antagonist-Ⅱ;
Portal vein tumor thrombus;
Recurrence;
Artificial intelligence
- From:
Organ Transplantation
2025;16(2):202-207
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is a highly prevalent malignant tumor worldwide and also the main indication for liver transplantation in China. The refined classification of transplant recipients has driven the evolution of indications for liver transplantation in HCC and is key to achieving precise liver transplantation. Tumor number and size have always been important clinical parameters limiting the eligibility of transplant recipients. The development of single-cell and spatial transcriptomics has further revealed the spatiotemporal heterogeneity of HCC. The incorporation of molecular markers into the criteria for liver transplantation in HCC represents a milestone. A classification system based on dual molecular markers can expand the pool of suitable candidates for liver transplantation while ensuring therapeutic efficacy. In recent years, the comprehensive diagnosis and treatment model for HCC represented by immunotherapy has made significant progress. The pre-transplant downstaging treatment system has become increasingly mature, allowing more patients who were previously unsuitable for transplantation to become eligible. The rise of artificial intelligence technology has also provided new tools for patient screening, classification, prognostic evaluation, and personalized treatment, further promoting the precision of liver transplantation in HCC. Therefore, this article reviews the scientific evolution of indications for liver transplantation in HCC and the role of artificial intelligence in revolutionizing the outcomes of liver transplantation for HCC patients, with the aim of benefiting more patients with HCC.
